CorMedix Completes Acquisition of Melinta Therapeutics, Raises Financial Guidance and Announces New Leadership Team

Benzinga
2025.09.02 12:09

- CorMedix 的一项变革性交易，扩展和多样化了公司的商业产品组合，包含七种创新药物产品以及一个具有近期收入增长潜力的管线扩展指示 -

Source: Benzinga The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.